An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Clinical trial NCT01085266 · TERMINATED
Trial details
- NCT number
- NCT01085266
- Sponsor
- Medivation, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-06-01
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.